Groupe Oncologie Radiotherapie Tete et Cou

• NCT04356170

  Phase 2, Completed, 105 people, 22 Apr 2020

• A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck

  Phase 3, Active, not recruiting, 680 people, 3 Jul 2018

• Trial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RT

  Phase 3, Active, not recruiting, 256 people, 14 Nov 2017

• Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC

  Phase 2, Active, not recruiting, 78 people, 3 Mar 2017

• Randomized Trial of Avelumab-cetuximab-radiotherapy Versus SOCs in LA SCCHN (REACH)

  Phase 3, Active, not recruiting, 707 people, 21 Dec 2016

• NCT02998385

  Phase 3, Active, not recruiting, 342 people, 20 Dec 2016

• NCT01233843

  Phase 3, Completed, 370 people, 3 Nov 2010

• NCT00609284

  Phase 3, Completed, 406 people, 7 Feb 2008

• NCT00174837

  Collaborator, Phase 3, Completed, 317 people, 15 Sept 2005

• NCT00169182

  Phase 3, Completed, 220 people, 15 Sept 2005

• NCT00017277

  Collaborator, Phase 3, Terminated, 47 people, 27 Jan 2003

Sources: clinicaltrials.gov